American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

TREACE MEDICAL CONCEPTS, INC. (TMCI)

$4.27 -0.23% NASDAQ: TMCI · 15-min delayed

PONTE VEDRA, Florida
Public · NASDAQ: TMCI
450 employees

Visit website Follow

$259.5MMarket cap

$212.7MRevenue · FY2025

-$59.0MNet income

450Employees

TMCINASDAQ

2021IPO

About TREACE MEDICAL CONCEPTS, INC.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: TMCI
Employees: 450
IPO date: Apr 23, 2021
Headquarters: 100 PALMETTO PARK PLACE
PONTE VEDRA, Florida 32081
Phone: (904) 373-5940
Industry: Medical Devices
Website: Visit site

Registry IDs

Ticker: TMCI Nasdaq
SEC CIK: 1630627
EIN: 471052611
SIC: 3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Treace Medical Concepts, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/treace-medical-concepts-inc/"><img src="https://americancompanies.com/badge/treace-medical-concepts-inc.svg" alt="Treace Medical Concepts, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow TREACE MEDICAL CONCEPTS, INC. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $212.7M
Net income: -$59.0M
Total assets: $190.6M
Market cap: $259.5M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: TMCI

$4.27 -0.23%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$1.20 $6.95

52-week range

Market cap: $259.5M
Shares outstanding: 60.8M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Apr 23, 2021

Treace Medical Concepts, Inc. (TMCI) Stock Price

Reported a net loss of $59.0M in FY2025.
Trading 39% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review TREACE MEDICAL CONCEPTS, INC..

Write a review

Newsroom

News about TREACE MEDICAL CONCEPTS, INC.

Johnson Fistel, PLLP Investigates Claims on Behalf of Long‑Term Shareholders of Quantum Computing Inc. (QUBT), Quanex Building Products Corporation (NX), Treace Medical Concepts, Inc. (TMCI), and BigBear.ai Holdings, Inc. (BBAI) GlobeNewswire Inc. · 2025-12-01 · negative Important Notice to Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); LuxUrban Hotels Inc. (OTC: LUXH); RCI Hospitality Holdings, Inc. (NASDAQ: RICK); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf Benzinga · 2025-09-26 · negative Treace Medical (TMCI) Q2 Revenue Up 7% The Motley Fool · 2025-08-08 · neutral Important Notice to Long-Term Shareholders of Methode Electronics, Inc. (NYSE: MEI); Manhattan Associates, Inc. (NASDAQ: MANH); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI); Grabar Law Office is Investigating Claims on Your Behalf GlobeNewswire Inc. · 2025-07-10 · negative Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); Manhattan Associates, Inc. (NASDAQ: MANH); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VIRT) GlobeNewswire Inc. · 2025-06-13 · negative TMCI Investors Have Final Opportunity to Lead Treace Medical Concepts, Inc. Securities Fraud Lawsuit with the Schall Law Firm Benzinga · 2025-06-09 · negative

News & sentiment via Polygon.io

FAQ

Treace Medical Concepts, Inc.: frequently asked questions

Is Treace Medical Concepts, Inc. an American company?

Treace Medical Concepts, Inc. is a US-based company headquartered in Ponte Vedra, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Treace Medical Concepts, Inc. headquartered?

Treace Medical Concepts, Inc. is headquartered in Ponte Vedra, Florida, United States.

Is Treace Medical Concepts, Inc. publicly traded?

Yes — Treace Medical Concepts, Inc. is a publicly traded company. Its stock trades under the ticker symbol TMCI on the NASDAQ.

What does Treace Medical Concepts, Inc. do?

Treace Medical Concepts, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore